MFDS — authorised 30 September 2013
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: likely_approved
🇰🇷 Trintellix in South Korea
MFDS authorised Trintellix on 30 September 2013
Marketing authorisation
Trintellix in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Trintellix approved in South Korea?
Yes. MFDS authorised it on 30 September 2013.
Who is the marketing authorisation holder for Trintellix in South Korea?
TAKEDA PHARMS USA holds the South Korean marketing authorisation.